Literature DB >> 22215186

Latent tuberculosis infection in children: diagnostic approaches.

V Amanatidou1, G Syridou, M Mavrikou, M N Tsolia.   

Abstract

Tuberculosis (TB) remains an important public health problem and a leading infectious cause of death. Diagnosis and treatment of latent tuberculosis infection (LTBI) is important for TB control and elimination. Nevertheless, the diagnosis of LTBI in both adults and children remains complex, since there is no gold standard. The development of interferon gamma release assays was a major breakthrough in the diagnosis of LTBI. The evaluation of IGRAs in the diagnosis of LTBI in children is proven to be difficult since childhood TB differs from adults as immune responses vary with age. Separate studies assessing IGRAs performance in children are still limited, and only a few of them divide results by narrow age groups Nevertheless, new approaches are being exploited by the ongoing research for the development of more efficient diagnostic tools. It is likely that many changes in both the diagnosis and management of LTBI will occur in the near future. We believe that better understanding of the immunopathology of latency can ultimately lead to the development of more effective strategies in TB control. In the present review we summarize current data on diagnosis of LTBI in children, underscoring the existing challenges and limitations.

Entities:  

Mesh:

Year:  2012        PMID: 22215186     DOI: 10.1007/s10096-011-1524-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  68 in total

1.  Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis.

Authors:  Jose Domínguez; Juan Ruiz-Manzano; Malú De Souza-Galvão; Irene Latorre; Celia Milà; Silvia Blanco; M Angeles Jiménez; Cristina Prat; Alicia Lacoma; Neus Altet; Vicente Ausina
Journal:  Clin Vaccine Immunol       Date:  2007-10-31

2.  The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.

Authors:  Shingai Machingaidze; Charles Shey Wiysonge; Yulieth Gonzalez-Angulo; Mark Hatherill; Sizulu Moyo; Willem Hanekom; Hassan Mahomed
Journal:  Pediatr Infect Dis J       Date:  2011-08       Impact factor: 2.129

Review 3.  Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis.

Authors:  Roland Diel; Robert Loddenkemper; Albert Nienhaus
Journal:  Chest       Date:  2009-12-18       Impact factor: 9.410

4.  Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact.

Authors:  Mustafa Bakir; Kerry A Millington; Ahmet Soysal; Jonathan J Deeks; Serpil Efee; Yasemin Aslan; Davinder P S Dosanjh; Ajit Lalvani
Journal:  Ann Intern Med       Date:  2008-10-20       Impact factor: 25.391

5.  Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis.

Authors:  Roland Diel; Robert Loddenkemper; Karen Meywald-Walter; Rene Gottschalk; Albert Nienhaus
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

6.  Interferon-gamma release assay improves the diagnosis of tuberculosis in children.

Authors:  Leila Bianchi; Luisa Galli; Maria Moriondo; Giuseppina Veneruso; Laura Becciolini; Chiara Azzari; Elena Chiappini; Maurizio de Martino
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

Review 7.  Paediatric tuberculosis.

Authors:  Sandra M Newton; Andrew J Brent; Suzanne Anderson; Elizabeth Whittaker; Beate Kampmann
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

8.  Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.

Authors:  B Kampmann; E Whittaker; A Williams; S Walters; A Gordon; N Martinez-Alier; B Williams; A M Crook; A-M Hutton; S T Anderson
Journal:  Eur Respir J       Date:  2009-02-05       Impact factor: 16.671

9.  T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination.

Authors:  Edita Hansted; Angele Andriuskeviciene; Raimundas Sakalauskas; Rimantas Kevalas; Brigita Sitkauskiene
Journal:  BMC Pulm Med       Date:  2009-08-18       Impact factor: 3.317

10.  Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting.

Authors:  Mark P Nicol; Mary-Ann Davies; Kathryn Wood; Mark Hatherill; Lesley Workman; Anthony Hawkridge; Brian Eley; Katalin A Wilkinson; Robert J Wilkinson; Willem A Hanekom; David Beatty; Gregory Hussey
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  6 in total

1.  Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.

Authors:  Elena Chiappini; Chiara Della Bella; Francesca Bonsignori; Sara Sollai; Amedeo Amedei; Luisa Galli; Elena Niccolai; Gianfranco Del Prete; Mahavir Singh; Mario M D'Elios; Maurizio de Martino
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

2.  miRNA signatures in sera of patients with active pulmonary tuberculosis.

Authors:  Paolo Miotto; Grace Mwangoka; Ilaria C Valente; Luca Norbis; Giovanni Sotgiu; Roberta Bosu; Alessandro Ambrosi; Luigi R Codecasa; Delia Goletti; Alberto Matteelli; Elias N Ntinginya; Francesco Aloi; Norbert Heinrich; Klaus Reither; Daniela M Cirillo
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

3.  IFN-γ and IL-2 Responses to Recombinant AlaDH against ESAT-6/CFP-10 Fusion Antigens in the Diagnosis of Latent versus Active Tuberculosis Infection.

Authors:  Bahram Movahedi; Pooneh Mokarram; Mina Hemmati; Nader Mosavari; Razie Zare; Leila Safaee Ardekani; Zohreh Mostafavi-Pour
Journal:  Iran J Med Sci       Date:  2017-05

4.  Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis.

Authors:  Anita G Amin; Prithwiraj De; Barbara Graham; Brooke L Jensen; Emmanuel Moreau; Delphi Chatterjee
Journal:  PLoS One       Date:  2022-10-11       Impact factor: 3.752

5.  Mycobacterium tuberculosis-specific TNF-α is a potential biomarker for the rapid diagnosis of active tuberculosis disease in Chinese population.

Authors:  Feng Wang; Hongyan Hou; Lingqing Xu; Munanie Jane; Jing Peng; Yanjun Lu; Yaowu Zhu; Ziyong Sun
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 6.  Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication).

Authors: 
Journal:  Intest Res       Date:  2018-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.